Lipid peroxidation and protein oxidation are related to the severity of OSAS

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 24, 2014, Pages 3773-3778

  Hopps, E ^a   Canino, B ^a   Calandrino, V ^a   Montana, M ^a   Lo Presti, R ^a   Caimi, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular risk; Lipid peroxidation; OSAS; Protein oxidation

Indexed keywords

CARBONYL DERIVATIVE; PROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; NECK CIRCUMFERENCE; OXIDATION; OXYGEN DESATURATION; OXYGEN SATURATION; PROTEIN MODIFICATION; SLEEP DISORDERED BREATHING; VENOUS BLOOD; WAIST CIRCUMFERENCE; AGED; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

AGED; FEMALE; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; WAIST CIRCUMFERENCE;

EID: 84929146066     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. EPSTEIN LJ, KRISTO D, STROLLO PJ JR, FRIEDMAN N, MALHOTRA A, PATIL S P, RAMAR K, ROGERS R., SCHWAB RJ, WEAVER EM, WEINSTEIN MD; Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009; 5: 263-276.
2. FREEDMAN N. Treatment of obstructive sleep apnea syndrome. Clin Chest Med 2010; 31: 187-201.
3. KENT BD, RYAN S, MCNICHOLAS WT Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 2011; 178: 475-481.
4. WANG X, OUYANG Y, WANG Z., ZHAO G, LIU L, BI Y. Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analy-sis of prospective cohort studies. Int J Cardiol 2013; 169: 207-214.
5. MARIN JM, CARRIZO SJ, VICENTE E, AGUSTI AG Longterm cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-1053.
6. QUERCIOLI A, MACH F, MONTECUCCO F. Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS). Sleep Breath 2010; 14: 261-269.
7. YAGGI HK, CONCATO J, KERNAN W.N., LICHTMAN JH, BRASS LM, MOHSENIN V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-2041.
8. SUZUKI YJ, JAIN V, PARK A.M., DAY RM. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006; 40: 1683-1692.
9. DALLE DONNE I., ROSSI R, COLOMBO R., GIUSTARINI D, MILZANI A. Biomarkers of oxidative damage in human disease. Clin Chem 2008; 524: 601-623
10. CELEC P, HODOSY J, BEHULIAK M., PÁLFFY R, GARDLÍK R, HALČÁK L, MUCSKA I. Oxidative and carbonyl stress in patients with obstructive sleep apnea treated with continuous positive airway pressure. Sleep Breath 2012; 16: 393-398.
11. MURRI M, ALCÁZAR-RAMÍREZ J, GARRIDO-SÁNCHEZ L, LINDE F, ALCAIDE J, CARDONA F, TINAHONES FJ. Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients. Transl Res 2009; 154: 111-121.
12. COFTA S, WYSOCKA E, PIORUNEK T., RZYMKOWSKA M, BATURA-GABRYEL H, TORLINSKI L. Oxidative stress markers in the blood of persons with different stages of obstructive sleep apnea syndrome. J Physiol Pharmacol 2008; 59: 183-190.
13. KIMOFF RJ, HAMID Q, DIVANGAHI M., HUSSAIN S, BAO W, NAOR N., PAYNE RJ, ARIYARAJAH A, MULRAIN K, PETROF BJ Increased upper airway cytokines and oxidative stress in severe obstructive sleep ap-noea. Eur Resp J 2010; 38: 89-97.
14. KATSOULIS K, KONTAKIOTIS T, SPANOGIANNIS D., VLA-CHOGIANNIS E, KOUGIOULIS M, GEROU S., DASKALOPOULOU E. Total antioxidant status in patients with obstructive sleep apnea without co-morbidities: the role of the severity of the disease. Sleep Breath 2011; 15: 861-866.
15. WYSOCKA E, COFTA S, CYMERYS M., GOZDZIK J, TORLINSKI L, BATURA-GABRYEL H. The impact of the sleep ap-nea syndrome on oxidant-antioxidant balance in the blood of overweight and obese patients. J Physiol Pharmacol 2008; 59: 761-769.
16. PAPANDREOU C. Levels of TBARS are inversely associated with lowest oxygen saturation in obese patients with OSAS. Sleep Breath 2013; 17: 1319-1322.
17. VATANSEVER E, SURMEN-GUR E, URSAVAS A., KARADAG M. Obstructive sleep apnea causes oxidative damage to plasma lipids and proteins and decreases adiponectin levels. Sleep Breath 2011; 15: 275-282.
18. CHEN PC, GUO CH, TSENG C.J., WANG KC, LIU PJ. Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea. J Nutr Health Aging 2013; 17: 639-644.
19. NTALAPASCHA M, MAKRIS D, KYPAROS A., TSILIONI I, KOSTIKAS K, GOURGOULIANIS K., KOURETAS D, ZAKYNTHI-NOS E. Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath 2013; 17: 549-555.
20. KANG IG, JUNG JH, KIM ST The effect of obstructive sleep apnea on DNA damage and oxidative stress. Clin Exp Otorhinolaryngol 2013; 6: 68-72.
21. Oztürk L., Mansour B, Yüksel M, Yalçin AS, Celikolu F, Gökhan N. Lipid peroxidation and osmotic fragility of red blood cells in sleep-apnea patients. Clin Chim Acta 2003; 332: 83-88.
22. YAGIHARA F, LUCCHESI LM, D'ALMEIDA V, MELLO MT, TU-FIK S, BITTENCOURT LR. Oxidative stress and quality of life in elderly patients with obstructive sleep ap-nea syndrome: are there differences after six months of continuous positive airway pressure treatment? Clinics (Sao Paulo) 2012; 67: 565-572.
23. KARAMANLI H, OZOL D, UGUR K.S., YILDIRIM Z., AR-MUTÇU F, BOZKURT B, YIGITOGLU R. Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 2014; 18: 251-256.
24. YANG XH, LIU X, SHANG J., LIU HG, XU YJ. Correlation between the serum level of advanced oxidation protein products and the cognitive function in patients with obstructive sleep apnea hypopnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 2013; 36: 274-279.
25. MANCUSO M, BONANNI E, LOGERFO A., ORSUCCI D, MAESTRI M, CHICO L., DICOSCIO E, FABBRINI M, SICIL-IANO G, MURRI L. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med 2012; 13: 632-636.
26. DI MASSIMO C., SCARPELLI P, DI LORENZO N, CAIMI G, DI ORIO F, CIANCARELLI MGT. Impaired plasma nitric oxide availability and extracellular superoxide dis-mutase activity in healthy humans with advancing age. Life Sci 2006; 78: 1163-1167.
27. LOWRY OH, ROSEBROUGH NJ, FARR A.L., RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
28. PUNJABI NM, CAFFO BS, GOODWIN J.L., GOTTLIEB DJ, NEWMAN AB, O'CONNOR GT, RAPOPORT DM, REDLINE S, RESNICK H.E., ROBBINS JA, SHAHAR E, UNRUH ML, SAMET JM Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009; 6: e1000132.
29. LAVIE L, LAVIE P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009; 33: 1467-1484.
30. JELIC S, LEDERER DJ, ADAMS T, PADELETTI M., COLOMBO PC, FACTOR PH, LE JEMTEL TH. Vascular inflammation in obesity and sleep apnea. Circulation 2010; 121: 1014-1012.